Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$2.08B |
| 2 |
Microsoft
MSFT
|
$699M |
| 3 |
Exxon Mobil
XOM
|
$614M |
| 4 |
Apple
AAPL
|
$587M |
| 5 |
UnitedHealth
UNH
|
$448M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1.1B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$477M |
| 3 |
GE Aerospace
GE
|
$375M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
$271M |
| 5 |
Applied Materials
AMAT
|
$209M |
Sector Composition
| 1 | Technology | 20.72% |
| 2 | Financials | 16.94% |
| 3 | Industrials | 12.29% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Blue Ridge Bankshares
BRBS
$374M
| $218K | ﹤0.01% |
83,623
-10,354
| -11% | -$27K |
|
3152
Maplebear
CART
$11.9B
| $218K | ﹤0.01% |
6,774
-428
| -6% | -$13.8K |
|
3153
Trevi Therapeutics
TRVI
$854M
| $215K | ﹤0.01% |
72,210
+49,475
| +218% | +$147K |
|
3154
Ovid Therapeutics
OVID
$87.5M
| $211K | ﹤0.01% |
274,982
-67,187
| -20% | -$51.6K |
|
3155
First National Corp
FXNC
$212M
| $211K | ﹤0.01% |
13,882
+1,595
| +13% | +$24.2K |
|
3156
Anavex Life Sciences
AVXL
$807M
| $209K | ﹤0.01% |
49,596
| – | – |
|
3157
Globalstar
GSAT
$3.96B
| $208K | ﹤0.01% |
12,416
-10,830
| -47% | -$182K |
|
3158
ALX Oncology
ALXO
$57.8M
| $208K | ﹤0.01% |
34,543
-15,798
| -31% | -$95.1K |
|
|
YSG
3159
Yatsen Holding
YSG
$881M
| $207K | ﹤0.01% |
+77,740
| New | +$207K |
|
3160
Seer Inc
SEER
$118M
| $206K | ﹤0.01% |
122,711
| – | – |
|
|
SRG
3161
Seritage Growth Properties
SRG
$211M
| $205K | ﹤0.01% |
44,077
-3,380
| -7% | -$15.8K |
|
3162
Turkcell
TKC
$4.83B
| $205K | ﹤0.01% |
26,993
+129
| +0.5% | +$978 |
|
3163
PMV Pharmaceuticals
PMVP
$77.4M
| $204K | ﹤0.01% |
126,004
-146,855
| -54% | -$238K |
|
3164
US Gold Corp
USAU
$175M
| $203K | ﹤0.01% |
39,191
-4,337
| -10% | -$22.4K |
|
|
HUT
3165
Hut 8
HUT
$2.68B
| $200K | ﹤0.01% |
+13,373
| New | +$200K |
|
|
ONCT
3166
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $200K | ﹤0.01% |
26,298
+406
| +2% | +$3.09K |
|
|
BRAG
3167
Bragg Gaming Group
BRAG
$67.8M
| $200K | ﹤0.01% |
+34,621
| New | +$200K |
|
3168
Byrna Technologies
BYRN
$445M
| $200K | ﹤0.01% |
20,016
+2,976
| +17% | +$29.7K |
|
|
ELEV
3169
DELISTED
Elevation Oncology
ELEV
| $197K | ﹤0.01% |
72,985
+4,637
| +7% | +$12.5K |
|
3170
The Beauty Health Co
SKIN
$260M
| $195K | ﹤0.01% |
101,476
-4,939
| -5% | -$9.48K |
|
3171
First Guaranty Bancshares
FGBI
$130M
| $192K | ﹤0.01% |
21,371
-3,121
| -13% | -$28.1K |
|
3172
Century Therapeutics
IPSC
$43.6M
| $192K | ﹤0.01% |
75,315
+44,155
| +142% | +$113K |
|
|
AZUL
3173
DELISTED
Azul
AZUL
| $191K | ﹤0.01% |
45,169
| – | – |
|
3174
American Well
AMWL
$113M
| $190K | ﹤0.01% |
29,180
-4,322
| -13% | -$28.2K |
|
|
THRD
3175
DELISTED
Third Harmonic Bio
THRD
| $188K | ﹤0.01% |
+14,468
| New | +$188K |
|